Global Hemoperfusion Market Growth 2026-2032
The global Hemoperfusion market size is predicted to grow from US$ 468 million in 2025 to US$ 810 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
This Insight Report provides a comprehensive analysis of the global Hemoperfusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Hemoperfusion Industry Forecast” looks at past sales and reviews total world Hemoperfusion sales in 2025, providing a comprehensive analysis by region and market sector of projected Hemoperfusion sales for 2026 through 2032. With Hemoperfusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion industry.This Insight Report provides a comprehensive analysis of the global Hemoperfusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Hemoperfusion Machine
- Hemoperfusion Cartridge
- Adsorption Column
- Hemoperfusion Bloodline Set
- Other
Segmentation by Feature:
- Plasma Perfusion
- Whole Blood Perfusion
Segmentation by Use Cases:
- Hospitals
- Blood Purification Centers
- Home Care
- Other
Segmentation by Application:
- End-Stage Kidney Disease And Uremic Toxin Accumulation
- Acute Drug and Toxin Poisoning
- Sepsis and Systemic Hyperinflammation
- Liver Failure and Hyperbilirubinemia
- Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jafron Biomedical
- Kangbei Medical
- Foshan Biosun Medical
- Chongqing Healthcom
- Weihai Weigao Life Technology
- Henan Tuoren Medical
- Guangzhou Koncen Biotech
- Chengdu OCI Medical
- Beijing Zhongke Shengkang
- Changguo Biomedicine Hebei
- Jiangsu Charity Biotechnology
- Chongqing Shanwaishan
- Vantive Health
- Toray Medical
- Kaneka Medix
- CytoSorbents
- Alteco Medical
- JIMRO
- Medica
- Bellco
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Hemoperfusion market?
- What factors are driving Hemoperfusion market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Hemoperfusion market opportunities vary by end market size?
- How does Hemoperfusion break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemoperfusion by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemoperfusion by Country/Region, 2021, 2025 & 2032
2.2 Hemoperfusion Segment by Type
2.2.1 Hemoperfusion Machine
2.2.2 Hemoperfusion Cartridge
2.2.3 Adsorption Column
2.2.4 Hemoperfusion Bloodline Set
2.2.5 Other
2.2.6 Hemoperfusion Sales by Type
2.2.6.1 Global Hemoperfusion Sales Market Share by Type (2021-2026)
2.2.6.2 Global Hemoperfusion Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Hemoperfusion Sale Price by Type (2021-2026)
2.3 Hemoperfusion Segment by Feature
2.3.1 Plasma Perfusion
2.3.2 Whole Blood Perfusion
2.3.3 Hemoperfusion Sales by Feature
2.3.3.1 Global Hemoperfusion Sales Market Share by Feature (2021-2026)
2.3.3.2 Global Hemoperfusion Revenue and Market Share by Feature (2021-2026)
2.3.3.3 Global Hemoperfusion Sale Price by Feature (2021-2026)
2.4 Hemoperfusion Segment by Use Cases
2.4.1 Hospitals
2.4.2 Blood Purification Centers
2.4.3 Home Care
2.4.4 Other
2.4.5 Hemoperfusion Sales by Use Cases
2.4.5.1 Global Hemoperfusion Sales Market Share by Use Cases (2021-2026)
2.4.5.2 Global Hemoperfusion Revenue and Market Share by Use Cases (2021-2026)
2.4.5.3 Global Hemoperfusion Sale Price by Use Cases (2021-2026)
2.5 Hemoperfusion Segment by Application
2.5.1 End-Stage Kidney Disease And Uremic Toxin Accumulation
2.5.2 Acute Drug and Toxin Poisoning
2.5.3 Sepsis and Systemic Hyperinflammation
2.5.4 Liver Failure and Hyperbilirubinemia
2.5.5 Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification
2.5.6 Other
2.5.7 Hemoperfusion Sales by Application
2.5.7.1 Global Hemoperfusion Sale Market Share by Application (2021-2026)
2.5.7.2 Global Hemoperfusion Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global Hemoperfusion Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Breakdown Data by Company
3.1.1 Global Hemoperfusion Annual Sales by Company (2021-2026)
3.1.2 Global Hemoperfusion Sales Market Share by Company (2021-2026)
3.2 Global Hemoperfusion Annual Revenue by Company (2021-2026)
3.2.1 Global Hemoperfusion Revenue by Company (2021-2026)
3.2.2 Global Hemoperfusion Revenue Market Share by Company (2021-2026)
3.3 Global Hemoperfusion Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Product Location Distribution
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemoperfusion Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemoperfusion Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemoperfusion Market Size by Country/Region (2021-2026)
4.2.1 Global Hemoperfusion Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemoperfusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemoperfusion Sales Growth
4.4 APAC Hemoperfusion Sales Growth
4.5 Europe Hemoperfusion Sales Growth
4.6 Middle East & Africa Hemoperfusion Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Sales by Country
5.1.1 Americas Hemoperfusion Sales by Country (2021-2026)
5.1.2 Americas Hemoperfusion Revenue by Country (2021-2026)
5.2 Americas Hemoperfusion Sales by Type (2021-2026)
5.3 Americas Hemoperfusion Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Sales by Region
6.1.1 APAC Hemoperfusion Sales by Region (2021-2026)
6.1.2 APAC Hemoperfusion Revenue by Region (2021-2026)
6.2 APAC Hemoperfusion Sales by Type (2021-2026)
6.3 APAC Hemoperfusion Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion by Country
7.1.1 Europe Hemoperfusion Sales by Country (2021-2026)
7.1.2 Europe Hemoperfusion Revenue by Country (2021-2026)
7.2 Europe Hemoperfusion Sales by Type (2021-2026)
7.3 Europe Hemoperfusion Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion by Country
8.1.1 Middle East & Africa Hemoperfusion Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemoperfusion Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemoperfusion Sales by Type (2021-2026)
8.3 Middle East & Africa Hemoperfusion Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion
10.3 Manufacturing Process Analysis of Hemoperfusion
10.4 Industry Chain Structure of Hemoperfusion
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Distributors
11.3 Hemoperfusion Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Market Size Forecast by Region
12.1.1 Global Hemoperfusion Forecast by Region (2027-2032)
12.1.2 Global Hemoperfusion Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemoperfusion Forecast by Type (2027-2032)
12.7 Global Hemoperfusion Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jafron Biomedical
13.1.1 Jafron Biomedical Company Information
13.1.2 Jafron Biomedical Hemoperfusion Product Portfolios and Specifications
13.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jafron Biomedical Main Business Overview
13.1.5 Jafron Biomedical Latest Developments
13.2 Kangbei Medical
13.2.1 Kangbei Medical Company Information
13.2.2 Kangbei Medical Hemoperfusion Product Portfolios and Specifications
13.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangbei Medical Main Business Overview
13.2.5 Kangbei Medical Latest Developments
13.3 Foshan Biosun Medical
13.3.1 Foshan Biosun Medical Company Information
13.3.2 Foshan Biosun Medical Hemoperfusion Product Portfolios and Specifications
13.3.3 Foshan Biosun Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Foshan Biosun Medical Main Business Overview
13.3.5 Foshan Biosun Medical Latest Developments
13.4 Chongqing Healthcom
13.4.1 Chongqing Healthcom Company Information
13.4.2 Chongqing Healthcom Hemoperfusion Product Portfolios and Specifications
13.4.3 Chongqing Healthcom Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Chongqing Healthcom Main Business Overview
13.4.5 Chongqing Healthcom Latest Developments
13.5 Weihai Weigao Life Technology
13.5.1 Weihai Weigao Life Technology Company Information
13.5.2 Weihai Weigao Life Technology Hemoperfusion Product Portfolios and Specifications
13.5.3 Weihai Weigao Life Technology Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Weihai Weigao Life Technology Main Business Overview
13.5.5 Weihai Weigao Life Technology Latest Developments
13.6 Henan Tuoren Medical
13.6.1 Henan Tuoren Medical Company Information
13.6.2 Henan Tuoren Medical Hemoperfusion Product Portfolios and Specifications
13.6.3 Henan Tuoren Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Henan Tuoren Medical Main Business Overview
13.6.5 Henan Tuoren Medical Latest Developments
13.7 Guangzhou Koncen Biotech
13.7.1 Guangzhou Koncen Biotech Company Information
13.7.2 Guangzhou Koncen Biotech Hemoperfusion Product Portfolios and Specifications
13.7.3 Guangzhou Koncen Biotech Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Guangzhou Koncen Biotech Main Business Overview
13.7.5 Guangzhou Koncen Biotech Latest Developments
13.8 Chengdu OCI Medical
13.8.1 Chengdu OCI Medical Company Information
13.8.2 Chengdu OCI Medical Hemoperfusion Product Portfolios and Specifications
13.8.3 Chengdu OCI Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chengdu OCI Medical Main Business Overview
13.8.5 Chengdu OCI Medical Latest Developments
13.9 Beijing Zhongke Shengkang
13.9.1 Beijing Zhongke Shengkang Company Information
13.9.2 Beijing Zhongke Shengkang Hemoperfusion Product Portfolios and Specifications
13.9.3 Beijing Zhongke Shengkang Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Zhongke Shengkang Main Business Overview
13.9.5 Beijing Zhongke Shengkang Latest Developments
13.10 Changguo Biomedicine Hebei
13.10.1 Changguo Biomedicine Hebei Company Information
13.10.2 Changguo Biomedicine Hebei Hemoperfusion Product Portfolios and Specifications
13.10.3 Changguo Biomedicine Hebei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Changguo Biomedicine Hebei Main Business Overview
13.10.5 Changguo Biomedicine Hebei Latest Developments
13.11 Jiangsu Charity Biotechnology
13.11.1 Jiangsu Charity Biotechnology Company Information
13.11.2 Jiangsu Charity Biotechnology Hemoperfusion Product Portfolios and Specifications
13.11.3 Jiangsu Charity Biotechnology Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Charity Biotechnology Main Business Overview
13.11.5 Jiangsu Charity Biotechnology Latest Developments
13.12 Chongqing Shanwaishan
13.12.1 Chongqing Shanwaishan Company Information
13.12.2 Chongqing Shanwaishan Hemoperfusion Product Portfolios and Specifications
13.12.3 Chongqing Shanwaishan Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chongqing Shanwaishan Main Business Overview
13.12.5 Chongqing Shanwaishan Latest Developments
13.13 Vantive Health
13.13.1 Vantive Health Company Information
13.13.2 Vantive Health Hemoperfusion Product Portfolios and Specifications
13.13.3 Vantive Health Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vantive Health Main Business Overview
13.13.5 Vantive Health Latest Developments
13.14 Toray Medical
13.14.1 Toray Medical Company Information
13.14.2 Toray Medical Hemoperfusion Product Portfolios and Specifications
13.14.3 Toray Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Toray Medical Main Business Overview
13.14.5 Toray Medical Latest Developments
13.15 Kaneka Medix
13.15.1 Kaneka Medix Company Information
13.15.2 Kaneka Medix Hemoperfusion Product Portfolios and Specifications
13.15.3 Kaneka Medix Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Kaneka Medix Main Business Overview
13.15.5 Kaneka Medix Latest Developments
13.16 CytoSorbents
13.16.1 CytoSorbents Company Information
13.16.2 CytoSorbents Hemoperfusion Product Portfolios and Specifications
13.16.3 CytoSorbents Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CytoSorbents Main Business Overview
13.16.5 CytoSorbents Latest Developments
13.17 Alteco Medical
13.17.1 Alteco Medical Company Information
13.17.2 Alteco Medical Hemoperfusion Product Portfolios and Specifications
13.17.3 Alteco Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Alteco Medical Main Business Overview
13.17.5 Alteco Medical Latest Developments
13.18 JIMRO
13.18.1 JIMRO Company Information
13.18.2 JIMRO Hemoperfusion Product Portfolios and Specifications
13.18.3 JIMRO Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 JIMRO Main Business Overview
13.18.5 JIMRO Latest Developments
13.19 Medica
13.19.1 Medica Company Information
13.19.2 Medica Hemoperfusion Product Portfolios and Specifications
13.19.3 Medica Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Medica Main Business Overview
13.19.5 Medica Latest Developments
13.20 Bellco
13.20.1 Bellco Company Information
13.20.2 Bellco Hemoperfusion Product Portfolios and Specifications
13.20.3 Bellco Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Bellco Main Business Overview
13.20.5 Bellco Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Hemoperfusion by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Hemoperfusion by Country/Region, 2021, 2025 & 2032
2.2 Hemoperfusion Segment by Type
2.2.1 Hemoperfusion Machine
2.2.2 Hemoperfusion Cartridge
2.2.3 Adsorption Column
2.2.4 Hemoperfusion Bloodline Set
2.2.5 Other
2.2.6 Hemoperfusion Sales by Type
2.2.6.1 Global Hemoperfusion Sales Market Share by Type (2021-2026)
2.2.6.2 Global Hemoperfusion Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Hemoperfusion Sale Price by Type (2021-2026)
2.3 Hemoperfusion Segment by Feature
2.3.1 Plasma Perfusion
2.3.2 Whole Blood Perfusion
2.3.3 Hemoperfusion Sales by Feature
2.3.3.1 Global Hemoperfusion Sales Market Share by Feature (2021-2026)
2.3.3.2 Global Hemoperfusion Revenue and Market Share by Feature (2021-2026)
2.3.3.3 Global Hemoperfusion Sale Price by Feature (2021-2026)
2.4 Hemoperfusion Segment by Use Cases
2.4.1 Hospitals
2.4.2 Blood Purification Centers
2.4.3 Home Care
2.4.4 Other
2.4.5 Hemoperfusion Sales by Use Cases
2.4.5.1 Global Hemoperfusion Sales Market Share by Use Cases (2021-2026)
2.4.5.2 Global Hemoperfusion Revenue and Market Share by Use Cases (2021-2026)
2.4.5.3 Global Hemoperfusion Sale Price by Use Cases (2021-2026)
2.5 Hemoperfusion Segment by Application
2.5.1 End-Stage Kidney Disease And Uremic Toxin Accumulation
2.5.2 Acute Drug and Toxin Poisoning
2.5.3 Sepsis and Systemic Hyperinflammation
2.5.4 Liver Failure and Hyperbilirubinemia
2.5.5 Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification
2.5.6 Other
2.5.7 Hemoperfusion Sales by Application
2.5.7.1 Global Hemoperfusion Sale Market Share by Application (2021-2026)
2.5.7.2 Global Hemoperfusion Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global Hemoperfusion Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Breakdown Data by Company
3.1.1 Global Hemoperfusion Annual Sales by Company (2021-2026)
3.1.2 Global Hemoperfusion Sales Market Share by Company (2021-2026)
3.2 Global Hemoperfusion Annual Revenue by Company (2021-2026)
3.2.1 Global Hemoperfusion Revenue by Company (2021-2026)
3.2.2 Global Hemoperfusion Revenue Market Share by Company (2021-2026)
3.3 Global Hemoperfusion Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Product Location Distribution
3.4.2 Players Hemoperfusion Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Market Size by Geographic Region (2021-2026)
4.1.1 Global Hemoperfusion Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Hemoperfusion Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Hemoperfusion Market Size by Country/Region (2021-2026)
4.2.1 Global Hemoperfusion Annual Sales by Country/Region (2021-2026)
4.2.2 Global Hemoperfusion Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hemoperfusion Sales Growth
4.4 APAC Hemoperfusion Sales Growth
4.5 Europe Hemoperfusion Sales Growth
4.6 Middle East & Africa Hemoperfusion Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Sales by Country
5.1.1 Americas Hemoperfusion Sales by Country (2021-2026)
5.1.2 Americas Hemoperfusion Revenue by Country (2021-2026)
5.2 Americas Hemoperfusion Sales by Type (2021-2026)
5.3 Americas Hemoperfusion Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Sales by Region
6.1.1 APAC Hemoperfusion Sales by Region (2021-2026)
6.1.2 APAC Hemoperfusion Revenue by Region (2021-2026)
6.2 APAC Hemoperfusion Sales by Type (2021-2026)
6.3 APAC Hemoperfusion Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion by Country
7.1.1 Europe Hemoperfusion Sales by Country (2021-2026)
7.1.2 Europe Hemoperfusion Revenue by Country (2021-2026)
7.2 Europe Hemoperfusion Sales by Type (2021-2026)
7.3 Europe Hemoperfusion Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion by Country
8.1.1 Middle East & Africa Hemoperfusion Sales by Country (2021-2026)
8.1.2 Middle East & Africa Hemoperfusion Revenue by Country (2021-2026)
8.2 Middle East & Africa Hemoperfusion Sales by Type (2021-2026)
8.3 Middle East & Africa Hemoperfusion Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion
10.3 Manufacturing Process Analysis of Hemoperfusion
10.4 Industry Chain Structure of Hemoperfusion
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Distributors
11.3 Hemoperfusion Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Market Size Forecast by Region
12.1.1 Global Hemoperfusion Forecast by Region (2027-2032)
12.1.2 Global Hemoperfusion Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Hemoperfusion Forecast by Type (2027-2032)
12.7 Global Hemoperfusion Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jafron Biomedical
13.1.1 Jafron Biomedical Company Information
13.1.2 Jafron Biomedical Hemoperfusion Product Portfolios and Specifications
13.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jafron Biomedical Main Business Overview
13.1.5 Jafron Biomedical Latest Developments
13.2 Kangbei Medical
13.2.1 Kangbei Medical Company Information
13.2.2 Kangbei Medical Hemoperfusion Product Portfolios and Specifications
13.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangbei Medical Main Business Overview
13.2.5 Kangbei Medical Latest Developments
13.3 Foshan Biosun Medical
13.3.1 Foshan Biosun Medical Company Information
13.3.2 Foshan Biosun Medical Hemoperfusion Product Portfolios and Specifications
13.3.3 Foshan Biosun Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Foshan Biosun Medical Main Business Overview
13.3.5 Foshan Biosun Medical Latest Developments
13.4 Chongqing Healthcom
13.4.1 Chongqing Healthcom Company Information
13.4.2 Chongqing Healthcom Hemoperfusion Product Portfolios and Specifications
13.4.3 Chongqing Healthcom Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Chongqing Healthcom Main Business Overview
13.4.5 Chongqing Healthcom Latest Developments
13.5 Weihai Weigao Life Technology
13.5.1 Weihai Weigao Life Technology Company Information
13.5.2 Weihai Weigao Life Technology Hemoperfusion Product Portfolios and Specifications
13.5.3 Weihai Weigao Life Technology Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Weihai Weigao Life Technology Main Business Overview
13.5.5 Weihai Weigao Life Technology Latest Developments
13.6 Henan Tuoren Medical
13.6.1 Henan Tuoren Medical Company Information
13.6.2 Henan Tuoren Medical Hemoperfusion Product Portfolios and Specifications
13.6.3 Henan Tuoren Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Henan Tuoren Medical Main Business Overview
13.6.5 Henan Tuoren Medical Latest Developments
13.7 Guangzhou Koncen Biotech
13.7.1 Guangzhou Koncen Biotech Company Information
13.7.2 Guangzhou Koncen Biotech Hemoperfusion Product Portfolios and Specifications
13.7.3 Guangzhou Koncen Biotech Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Guangzhou Koncen Biotech Main Business Overview
13.7.5 Guangzhou Koncen Biotech Latest Developments
13.8 Chengdu OCI Medical
13.8.1 Chengdu OCI Medical Company Information
13.8.2 Chengdu OCI Medical Hemoperfusion Product Portfolios and Specifications
13.8.3 Chengdu OCI Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chengdu OCI Medical Main Business Overview
13.8.5 Chengdu OCI Medical Latest Developments
13.9 Beijing Zhongke Shengkang
13.9.1 Beijing Zhongke Shengkang Company Information
13.9.2 Beijing Zhongke Shengkang Hemoperfusion Product Portfolios and Specifications
13.9.3 Beijing Zhongke Shengkang Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Beijing Zhongke Shengkang Main Business Overview
13.9.5 Beijing Zhongke Shengkang Latest Developments
13.10 Changguo Biomedicine Hebei
13.10.1 Changguo Biomedicine Hebei Company Information
13.10.2 Changguo Biomedicine Hebei Hemoperfusion Product Portfolios and Specifications
13.10.3 Changguo Biomedicine Hebei Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Changguo Biomedicine Hebei Main Business Overview
13.10.5 Changguo Biomedicine Hebei Latest Developments
13.11 Jiangsu Charity Biotechnology
13.11.1 Jiangsu Charity Biotechnology Company Information
13.11.2 Jiangsu Charity Biotechnology Hemoperfusion Product Portfolios and Specifications
13.11.3 Jiangsu Charity Biotechnology Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Charity Biotechnology Main Business Overview
13.11.5 Jiangsu Charity Biotechnology Latest Developments
13.12 Chongqing Shanwaishan
13.12.1 Chongqing Shanwaishan Company Information
13.12.2 Chongqing Shanwaishan Hemoperfusion Product Portfolios and Specifications
13.12.3 Chongqing Shanwaishan Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chongqing Shanwaishan Main Business Overview
13.12.5 Chongqing Shanwaishan Latest Developments
13.13 Vantive Health
13.13.1 Vantive Health Company Information
13.13.2 Vantive Health Hemoperfusion Product Portfolios and Specifications
13.13.3 Vantive Health Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vantive Health Main Business Overview
13.13.5 Vantive Health Latest Developments
13.14 Toray Medical
13.14.1 Toray Medical Company Information
13.14.2 Toray Medical Hemoperfusion Product Portfolios and Specifications
13.14.3 Toray Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Toray Medical Main Business Overview
13.14.5 Toray Medical Latest Developments
13.15 Kaneka Medix
13.15.1 Kaneka Medix Company Information
13.15.2 Kaneka Medix Hemoperfusion Product Portfolios and Specifications
13.15.3 Kaneka Medix Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Kaneka Medix Main Business Overview
13.15.5 Kaneka Medix Latest Developments
13.16 CytoSorbents
13.16.1 CytoSorbents Company Information
13.16.2 CytoSorbents Hemoperfusion Product Portfolios and Specifications
13.16.3 CytoSorbents Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CytoSorbents Main Business Overview
13.16.5 CytoSorbents Latest Developments
13.17 Alteco Medical
13.17.1 Alteco Medical Company Information
13.17.2 Alteco Medical Hemoperfusion Product Portfolios and Specifications
13.17.3 Alteco Medical Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Alteco Medical Main Business Overview
13.17.5 Alteco Medical Latest Developments
13.18 JIMRO
13.18.1 JIMRO Company Information
13.18.2 JIMRO Hemoperfusion Product Portfolios and Specifications
13.18.3 JIMRO Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 JIMRO Main Business Overview
13.18.5 JIMRO Latest Developments
13.19 Medica
13.19.1 Medica Company Information
13.19.2 Medica Hemoperfusion Product Portfolios and Specifications
13.19.3 Medica Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Medica Main Business Overview
13.19.5 Medica Latest Developments
13.20 Bellco
13.20.1 Bellco Company Information
13.20.2 Bellco Hemoperfusion Product Portfolios and Specifications
13.20.3 Bellco Hemoperfusion Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Bellco Main Business Overview
13.20.5 Bellco Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemoperfusion Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemoperfusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemoperfusion Machine
Table 4. Major Players of Hemoperfusion Cartridge
Table 5. Major Players of Adsorption Column
Table 6. Major Players of Hemoperfusion Bloodline Set
Table 7. Major Players of Other
Table 8. Global Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 9. Global Hemoperfusion Sales Market Share by Type (2021-2026)
Table 10. Global Hemoperfusion Revenue by Type (2021-2026) & ($ million)
Table 11. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Table 12. Global Hemoperfusion Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Plasma Perfusion
Table 14. Major Players of Whole Blood Perfusion
Table 15. Global Hemoperfusion Sales by Feature (2021-2026) & (K Units)
Table 16. Global Hemoperfusion Sales Market Share by Feature (2021-2026)
Table 17. Global Hemoperfusion Revenue by Feature (2021-2026) & ($ million)
Table 18. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Table 19. Global Hemoperfusion Sale Price by Feature (2021-2026) & (US$/Unit)
Table 20. Major Players of Hospitals
Table 21. Major Players of Blood Purification Centers
Table 22. Major Players of Home Care
Table 23. Major Players of Other
Table 24. Global Hemoperfusion Sales by Use Cases (2021-2026) & (K Units)
Table 25. Global Hemoperfusion Sales Market Share by Use Cases (2021-2026)
Table 26. Global Hemoperfusion Revenue by Use Cases (2021-2026) & ($ million)
Table 27. Global Hemoperfusion Revenue Market Share by Use Cases (2021-2026)
Table 28. Global Hemoperfusion Sale Price by Use Cases (2021-2026) & (US$/Unit)
Table 29. Global Hemoperfusion Sale by Application (2021-2026) & (K Units)
Table 30. Global Hemoperfusion Sale Market Share by Application (2021-2026)
Table 31. Global Hemoperfusion Revenue by Application (2021-2026) & ($ million)
Table 32. Global Hemoperfusion Revenue Market Share by Application (2021-2026)
Table 33. Global Hemoperfusion Sale Price by Application (2021-2026) & (US$/Unit)
Table 34. Global Hemoperfusion Sales by Company (2021-2026) & (K Units)
Table 35. Global Hemoperfusion Sales Market Share by Company (2021-2026)
Table 36. Global Hemoperfusion Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Hemoperfusion Revenue Market Share by Company (2021-2026)
Table 38. Global Hemoperfusion Sale Price by Company (2021-2026) & (US$/Unit)
Table 39. Key Manufacturers Hemoperfusion Producing Area Distribution and Sales Area
Table 40. Players Hemoperfusion Products Offered
Table 41. Hemoperfusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Hemoperfusion Sales by Geographic Region (2021-2026) & (K Units)
Table 45. Global Hemoperfusion Sales Market Share Geographic Region (2021-2026)
Table 46. Global Hemoperfusion Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Hemoperfusion Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Hemoperfusion Sales by Country/Region (2021-2026) & (K Units)
Table 49. Global Hemoperfusion Sales Market Share by Country/Region (2021-2026)
Table 50. Global Hemoperfusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Hemoperfusion Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 53. Americas Hemoperfusion Sales Market Share by Country (2021-2026)
Table 54. Americas Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 56. Americas Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 57. APAC Hemoperfusion Sales by Region (2021-2026) & (K Units)
Table 58. APAC Hemoperfusion Sales Market Share by Region (2021-2026)
Table 59. APAC Hemoperfusion Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 61. APAC Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 62. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 63. Europe Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 65. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 66. Middle East & Africa Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 67. Middle East & Africa Hemoperfusion Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 69. Middle East & Africa Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 70. Key Market Drivers & Growth Opportunities of Hemoperfusion
Table 71. Key Market Challenges & Risks of Hemoperfusion
Table 72. Key Industry Trends of Hemoperfusion
Table 73. Hemoperfusion Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Hemoperfusion Distributors List
Table 76. Hemoperfusion Customer List
Table 77. Global Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 78. Global Hemoperfusion Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Americas Hemoperfusion Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 82. APAC Hemoperfusion Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Europe Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Middle East & Africa Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Hemoperfusion Sales Forecast by Type (2027-2032) & (K Units)
Table 88. Global Hemoperfusion Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Hemoperfusion Sales Forecast by Application (2027-2032) & (K Units)
Table 90. Global Hemoperfusion Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Jafron Biomedical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 92. Jafron Biomedical Hemoperfusion Product Portfolios and Specifications
Table 93. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Jafron Biomedical Main Business
Table 95. Jafron Biomedical Latest Developments
Table 96. Kangbei Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 97. Kangbei Medical Hemoperfusion Product Portfolios and Specifications
Table 98. Kangbei Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Kangbei Medical Main Business
Table 100. Kangbei Medical Latest Developments
Table 101. Foshan Biosun Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 102. Foshan Biosun Medical Hemoperfusion Product Portfolios and Specifications
Table 103. Foshan Biosun Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Foshan Biosun Medical Main Business
Table 105. Foshan Biosun Medical Latest Developments
Table 106. Chongqing Healthcom Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 107. Chongqing Healthcom Hemoperfusion Product Portfolios and Specifications
Table 108. Chongqing Healthcom Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Chongqing Healthcom Main Business
Table 110. Chongqing Healthcom Latest Developments
Table 111. Weihai Weigao Life Technology Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 112. Weihai Weigao Life Technology Hemoperfusion Product Portfolios and Specifications
Table 113. Weihai Weigao Life Technology Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Weihai Weigao Life Technology Main Business
Table 115. Weihai Weigao Life Technology Latest Developments
Table 116. Henan Tuoren Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 117. Henan Tuoren Medical Hemoperfusion Product Portfolios and Specifications
Table 118. Henan Tuoren Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Henan Tuoren Medical Main Business
Table 120. Henan Tuoren Medical Latest Developments
Table 121. Guangzhou Koncen Biotech Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 122. Guangzhou Koncen Biotech Hemoperfusion Product Portfolios and Specifications
Table 123. Guangzhou Koncen Biotech Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Guangzhou Koncen Biotech Main Business
Table 125. Guangzhou Koncen Biotech Latest Developments
Table 126. Chengdu OCI Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 127. Chengdu OCI Medical Hemoperfusion Product Portfolios and Specifications
Table 128. Chengdu OCI Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Chengdu OCI Medical Main Business
Table 130. Chengdu OCI Medical Latest Developments
Table 131. Beijing Zhongke Shengkang Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 132. Beijing Zhongke Shengkang Hemoperfusion Product Portfolios and Specifications
Table 133. Beijing Zhongke Shengkang Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Beijing Zhongke Shengkang Main Business
Table 135. Beijing Zhongke Shengkang Latest Developments
Table 136. Changguo Biomedicine Hebei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 137. Changguo Biomedicine Hebei Hemoperfusion Product Portfolios and Specifications
Table 138. Changguo Biomedicine Hebei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Changguo Biomedicine Hebei Main Business
Table 140. Changguo Biomedicine Hebei Latest Developments
Table 141. Jiangsu Charity Biotechnology Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 142. Jiangsu Charity Biotechnology Hemoperfusion Product Portfolios and Specifications
Table 143. Jiangsu Charity Biotechnology Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Jiangsu Charity Biotechnology Main Business
Table 145. Jiangsu Charity Biotechnology Latest Developments
Table 146. Chongqing Shanwaishan Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 147. Chongqing Shanwaishan Hemoperfusion Product Portfolios and Specifications
Table 148. Chongqing Shanwaishan Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Chongqing Shanwaishan Main Business
Table 150. Chongqing Shanwaishan Latest Developments
Table 151. Vantive Health Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 152. Vantive Health Hemoperfusion Product Portfolios and Specifications
Table 153. Vantive Health Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Vantive Health Main Business
Table 155. Vantive Health Latest Developments
Table 156. Toray Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 157. Toray Medical Hemoperfusion Product Portfolios and Specifications
Table 158. Toray Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Toray Medical Main Business
Table 160. Toray Medical Latest Developments
Table 161. Kaneka Medix Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 162. Kaneka Medix Hemoperfusion Product Portfolios and Specifications
Table 163. Kaneka Medix Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Kaneka Medix Main Business
Table 165. Kaneka Medix Latest Developments
Table 166. CytoSorbents Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 167. CytoSorbents Hemoperfusion Product Portfolios and Specifications
Table 168. CytoSorbents Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 169. CytoSorbents Main Business
Table 170. CytoSorbents Latest Developments
Table 171. Alteco Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 172. Alteco Medical Hemoperfusion Product Portfolios and Specifications
Table 173. Alteco Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 174. Alteco Medical Main Business
Table 175. Alteco Medical Latest Developments
Table 176. JIMRO Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 177. JIMRO Hemoperfusion Product Portfolios and Specifications
Table 178. JIMRO Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 179. JIMRO Main Business
Table 180. JIMRO Latest Developments
Table 181. Medica Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 182. Medica Hemoperfusion Product Portfolios and Specifications
Table 183. Medica Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 184. Medica Main Business
Table 185. Medica Latest Developments
Table 186. Bellco Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 187. Bellco Hemoperfusion Product Portfolios and Specifications
Table 188. Bellco Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 189. Bellco Main Business
Table 190. Bellco Latest Developments
Table 1. Hemoperfusion Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Hemoperfusion Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemoperfusion Machine
Table 4. Major Players of Hemoperfusion Cartridge
Table 5. Major Players of Adsorption Column
Table 6. Major Players of Hemoperfusion Bloodline Set
Table 7. Major Players of Other
Table 8. Global Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 9. Global Hemoperfusion Sales Market Share by Type (2021-2026)
Table 10. Global Hemoperfusion Revenue by Type (2021-2026) & ($ million)
Table 11. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Table 12. Global Hemoperfusion Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Plasma Perfusion
Table 14. Major Players of Whole Blood Perfusion
Table 15. Global Hemoperfusion Sales by Feature (2021-2026) & (K Units)
Table 16. Global Hemoperfusion Sales Market Share by Feature (2021-2026)
Table 17. Global Hemoperfusion Revenue by Feature (2021-2026) & ($ million)
Table 18. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Table 19. Global Hemoperfusion Sale Price by Feature (2021-2026) & (US$/Unit)
Table 20. Major Players of Hospitals
Table 21. Major Players of Blood Purification Centers
Table 22. Major Players of Home Care
Table 23. Major Players of Other
Table 24. Global Hemoperfusion Sales by Use Cases (2021-2026) & (K Units)
Table 25. Global Hemoperfusion Sales Market Share by Use Cases (2021-2026)
Table 26. Global Hemoperfusion Revenue by Use Cases (2021-2026) & ($ million)
Table 27. Global Hemoperfusion Revenue Market Share by Use Cases (2021-2026)
Table 28. Global Hemoperfusion Sale Price by Use Cases (2021-2026) & (US$/Unit)
Table 29. Global Hemoperfusion Sale by Application (2021-2026) & (K Units)
Table 30. Global Hemoperfusion Sale Market Share by Application (2021-2026)
Table 31. Global Hemoperfusion Revenue by Application (2021-2026) & ($ million)
Table 32. Global Hemoperfusion Revenue Market Share by Application (2021-2026)
Table 33. Global Hemoperfusion Sale Price by Application (2021-2026) & (US$/Unit)
Table 34. Global Hemoperfusion Sales by Company (2021-2026) & (K Units)
Table 35. Global Hemoperfusion Sales Market Share by Company (2021-2026)
Table 36. Global Hemoperfusion Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Hemoperfusion Revenue Market Share by Company (2021-2026)
Table 38. Global Hemoperfusion Sale Price by Company (2021-2026) & (US$/Unit)
Table 39. Key Manufacturers Hemoperfusion Producing Area Distribution and Sales Area
Table 40. Players Hemoperfusion Products Offered
Table 41. Hemoperfusion Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Hemoperfusion Sales by Geographic Region (2021-2026) & (K Units)
Table 45. Global Hemoperfusion Sales Market Share Geographic Region (2021-2026)
Table 46. Global Hemoperfusion Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Hemoperfusion Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Hemoperfusion Sales by Country/Region (2021-2026) & (K Units)
Table 49. Global Hemoperfusion Sales Market Share by Country/Region (2021-2026)
Table 50. Global Hemoperfusion Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Hemoperfusion Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 53. Americas Hemoperfusion Sales Market Share by Country (2021-2026)
Table 54. Americas Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 56. Americas Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 57. APAC Hemoperfusion Sales by Region (2021-2026) & (K Units)
Table 58. APAC Hemoperfusion Sales Market Share by Region (2021-2026)
Table 59. APAC Hemoperfusion Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 61. APAC Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 62. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 63. Europe Hemoperfusion Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 65. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 66. Middle East & Africa Hemoperfusion Sales by Country (2021-2026) & (K Units)
Table 67. Middle East & Africa Hemoperfusion Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Hemoperfusion Sales by Type (2021-2026) & (K Units)
Table 69. Middle East & Africa Hemoperfusion Sales by Application (2021-2026) & (K Units)
Table 70. Key Market Drivers & Growth Opportunities of Hemoperfusion
Table 71. Key Market Challenges & Risks of Hemoperfusion
Table 72. Key Industry Trends of Hemoperfusion
Table 73. Hemoperfusion Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Hemoperfusion Distributors List
Table 76. Hemoperfusion Customer List
Table 77. Global Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 78. Global Hemoperfusion Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Americas Hemoperfusion Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Hemoperfusion Sales Forecast by Region (2027-2032) & (K Units)
Table 82. APAC Hemoperfusion Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Europe Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Middle East & Africa Hemoperfusion Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Hemoperfusion Sales Forecast by Type (2027-2032) & (K Units)
Table 88. Global Hemoperfusion Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Hemoperfusion Sales Forecast by Application (2027-2032) & (K Units)
Table 90. Global Hemoperfusion Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Jafron Biomedical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 92. Jafron Biomedical Hemoperfusion Product Portfolios and Specifications
Table 93. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Jafron Biomedical Main Business
Table 95. Jafron Biomedical Latest Developments
Table 96. Kangbei Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 97. Kangbei Medical Hemoperfusion Product Portfolios and Specifications
Table 98. Kangbei Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Kangbei Medical Main Business
Table 100. Kangbei Medical Latest Developments
Table 101. Foshan Biosun Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 102. Foshan Biosun Medical Hemoperfusion Product Portfolios and Specifications
Table 103. Foshan Biosun Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Foshan Biosun Medical Main Business
Table 105. Foshan Biosun Medical Latest Developments
Table 106. Chongqing Healthcom Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 107. Chongqing Healthcom Hemoperfusion Product Portfolios and Specifications
Table 108. Chongqing Healthcom Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Chongqing Healthcom Main Business
Table 110. Chongqing Healthcom Latest Developments
Table 111. Weihai Weigao Life Technology Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 112. Weihai Weigao Life Technology Hemoperfusion Product Portfolios and Specifications
Table 113. Weihai Weigao Life Technology Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Weihai Weigao Life Technology Main Business
Table 115. Weihai Weigao Life Technology Latest Developments
Table 116. Henan Tuoren Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 117. Henan Tuoren Medical Hemoperfusion Product Portfolios and Specifications
Table 118. Henan Tuoren Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Henan Tuoren Medical Main Business
Table 120. Henan Tuoren Medical Latest Developments
Table 121. Guangzhou Koncen Biotech Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 122. Guangzhou Koncen Biotech Hemoperfusion Product Portfolios and Specifications
Table 123. Guangzhou Koncen Biotech Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Guangzhou Koncen Biotech Main Business
Table 125. Guangzhou Koncen Biotech Latest Developments
Table 126. Chengdu OCI Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 127. Chengdu OCI Medical Hemoperfusion Product Portfolios and Specifications
Table 128. Chengdu OCI Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Chengdu OCI Medical Main Business
Table 130. Chengdu OCI Medical Latest Developments
Table 131. Beijing Zhongke Shengkang Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 132. Beijing Zhongke Shengkang Hemoperfusion Product Portfolios and Specifications
Table 133. Beijing Zhongke Shengkang Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Beijing Zhongke Shengkang Main Business
Table 135. Beijing Zhongke Shengkang Latest Developments
Table 136. Changguo Biomedicine Hebei Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 137. Changguo Biomedicine Hebei Hemoperfusion Product Portfolios and Specifications
Table 138. Changguo Biomedicine Hebei Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Changguo Biomedicine Hebei Main Business
Table 140. Changguo Biomedicine Hebei Latest Developments
Table 141. Jiangsu Charity Biotechnology Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 142. Jiangsu Charity Biotechnology Hemoperfusion Product Portfolios and Specifications
Table 143. Jiangsu Charity Biotechnology Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Jiangsu Charity Biotechnology Main Business
Table 145. Jiangsu Charity Biotechnology Latest Developments
Table 146. Chongqing Shanwaishan Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 147. Chongqing Shanwaishan Hemoperfusion Product Portfolios and Specifications
Table 148. Chongqing Shanwaishan Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Chongqing Shanwaishan Main Business
Table 150. Chongqing Shanwaishan Latest Developments
Table 151. Vantive Health Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 152. Vantive Health Hemoperfusion Product Portfolios and Specifications
Table 153. Vantive Health Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Vantive Health Main Business
Table 155. Vantive Health Latest Developments
Table 156. Toray Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 157. Toray Medical Hemoperfusion Product Portfolios and Specifications
Table 158. Toray Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Toray Medical Main Business
Table 160. Toray Medical Latest Developments
Table 161. Kaneka Medix Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 162. Kaneka Medix Hemoperfusion Product Portfolios and Specifications
Table 163. Kaneka Medix Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Kaneka Medix Main Business
Table 165. Kaneka Medix Latest Developments
Table 166. CytoSorbents Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 167. CytoSorbents Hemoperfusion Product Portfolios and Specifications
Table 168. CytoSorbents Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 169. CytoSorbents Main Business
Table 170. CytoSorbents Latest Developments
Table 171. Alteco Medical Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 172. Alteco Medical Hemoperfusion Product Portfolios and Specifications
Table 173. Alteco Medical Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 174. Alteco Medical Main Business
Table 175. Alteco Medical Latest Developments
Table 176. JIMRO Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 177. JIMRO Hemoperfusion Product Portfolios and Specifications
Table 178. JIMRO Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 179. JIMRO Main Business
Table 180. JIMRO Latest Developments
Table 181. Medica Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 182. Medica Hemoperfusion Product Portfolios and Specifications
Table 183. Medica Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 184. Medica Main Business
Table 185. Medica Latest Developments
Table 186. Bellco Basic Information, Hemoperfusion Manufacturing Base, Sales Area and Its Competitors
Table 187. Bellco Hemoperfusion Product Portfolios and Specifications
Table 188. Bellco Hemoperfusion Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 189. Bellco Main Business
Table 190. Bellco Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hemoperfusion
Figure 2. Hemoperfusion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemoperfusion Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemoperfusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemoperfusion Sales Market Share by Country/Region (2025)
Figure 10. Hemoperfusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemoperfusion Machine
Figure 12. Product Picture of Hemoperfusion Cartridge
Figure 13. Product Picture of Adsorption Column
Figure 14. Product Picture of Hemoperfusion Bloodline Set
Figure 15. Product Picture of Other
Figure 16. Global Hemoperfusion Sales Market Share by Type in 2026
Figure 17. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Plasma Perfusion
Figure 19. Product Picture of Whole Blood Perfusion
Figure 20. Global Hemoperfusion Sales Market Share by Feature in 2026
Figure 21. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Figure 22. Product Picture of Hospitals
Figure 23. Product Picture of Blood Purification Centers
Figure 24. Product Picture of Home Care
Figure 25. Product Picture of Other
Figure 26. Global Hemoperfusion Sales Market Share by Use Cases in 2026
Figure 27. Global Hemoperfusion Revenue Market Share by Use Cases (2021-2026)
Figure 28. Hemoperfusion Consumed in End-Stage Kidney Disease And Uremic Toxin Accumulation
Figure 29. Global Hemoperfusion Market: End-Stage Kidney Disease And Uremic Toxin Accumulation (2021-2026) & (K Units)
Figure 30. Hemoperfusion Consumed in Acute Drug and Toxin Poisoning
Figure 31. Global Hemoperfusion Market: Acute Drug and Toxin Poisoning (2021-2026) & (K Units)
Figure 32. Hemoperfusion Consumed in Sepsis and Systemic Hyperinflammation
Figure 33. Global Hemoperfusion Market: Sepsis and Systemic Hyperinflammation (2021-2026) & (K Units)
Figure 34. Hemoperfusion Consumed in Liver Failure and Hyperbilirubinemia
Figure 35. Global Hemoperfusion Market: Liver Failure and Hyperbilirubinemia (2021-2026) & (K Units)
Figure 36. Hemoperfusion Consumed in Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification
Figure 37. Global Hemoperfusion Market: Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification (2021-2026) & (K Units)
Figure 38. Hemoperfusion Consumed in Other
Figure 39. Global Hemoperfusion Market: Other (2021-2026) & (K Units)
Figure 40. Global Hemoperfusion Sale Market Share by Application (2025)
Figure 41. Global Hemoperfusion Revenue Market Share by Application in 2025
Figure 42. Hemoperfusion Sales by Company in 2025 (K Units)
Figure 43. Global Hemoperfusion Sales Market Share by Company in 2025
Figure 44. Hemoperfusion Revenue by Company in 2025 ($ millions)
Figure 45. Global Hemoperfusion Revenue Market Share by Company in 2025
Figure 46. Global Hemoperfusion Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Hemoperfusion Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Hemoperfusion Sales 2021-2026 (K Units)
Figure 49. Americas Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 50. APAC Hemoperfusion Sales 2021-2026 (K Units)
Figure 51. APAC Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 52. Europe Hemoperfusion Sales 2021-2026 (K Units)
Figure 53. Europe Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Hemoperfusion Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 56. Americas Hemoperfusion Sales Market Share by Country in 2025
Figure 57. Americas Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 58. Americas Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 59. Americas Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 60. United States Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Hemoperfusion Sales Market Share by Region in 2025
Figure 65. APAC Hemoperfusion Revenue Market Share by Region (2021-2026)
Figure 66. APAC Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 67. APAC Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 68. China Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 72. India Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Hemoperfusion Sales Market Share by Country in 2025
Figure 76. Europe Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 77. Europe Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 78. Europe Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 79. Germany Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 80. France Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Hemoperfusion Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 87. Egypt Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Hemoperfusion in 2026
Figure 93. Manufacturing Process Analysis of Hemoperfusion
Figure 94. Industry Chain Structure of Hemoperfusion
Figure 95. Channels of Distribution
Figure 96. Global Hemoperfusion Sales Market Forecast by Region (2027-2032)
Figure 97. Global Hemoperfusion Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Hemoperfusion Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Hemoperfusion Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Hemoperfusion Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Hemoperfusion Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Hemoperfusion
Figure 2. Hemoperfusion Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Hemoperfusion Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Hemoperfusion Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Hemoperfusion Sales Market Share by Country/Region (2025)
Figure 10. Hemoperfusion Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemoperfusion Machine
Figure 12. Product Picture of Hemoperfusion Cartridge
Figure 13. Product Picture of Adsorption Column
Figure 14. Product Picture of Hemoperfusion Bloodline Set
Figure 15. Product Picture of Other
Figure 16. Global Hemoperfusion Sales Market Share by Type in 2026
Figure 17. Global Hemoperfusion Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Plasma Perfusion
Figure 19. Product Picture of Whole Blood Perfusion
Figure 20. Global Hemoperfusion Sales Market Share by Feature in 2026
Figure 21. Global Hemoperfusion Revenue Market Share by Feature (2021-2026)
Figure 22. Product Picture of Hospitals
Figure 23. Product Picture of Blood Purification Centers
Figure 24. Product Picture of Home Care
Figure 25. Product Picture of Other
Figure 26. Global Hemoperfusion Sales Market Share by Use Cases in 2026
Figure 27. Global Hemoperfusion Revenue Market Share by Use Cases (2021-2026)
Figure 28. Hemoperfusion Consumed in End-Stage Kidney Disease And Uremic Toxin Accumulation
Figure 29. Global Hemoperfusion Market: End-Stage Kidney Disease And Uremic Toxin Accumulation (2021-2026) & (K Units)
Figure 30. Hemoperfusion Consumed in Acute Drug and Toxin Poisoning
Figure 31. Global Hemoperfusion Market: Acute Drug and Toxin Poisoning (2021-2026) & (K Units)
Figure 32. Hemoperfusion Consumed in Sepsis and Systemic Hyperinflammation
Figure 33. Global Hemoperfusion Market: Sepsis and Systemic Hyperinflammation (2021-2026) & (K Units)
Figure 34. Hemoperfusion Consumed in Liver Failure and Hyperbilirubinemia
Figure 35. Global Hemoperfusion Market: Liver Failure and Hyperbilirubinemia (2021-2026) & (K Units)
Figure 36. Hemoperfusion Consumed in Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification
Figure 37. Global Hemoperfusion Market: Autoimmune and Metabolic Disorders Requiring Adsorptive Blood Purification (2021-2026) & (K Units)
Figure 38. Hemoperfusion Consumed in Other
Figure 39. Global Hemoperfusion Market: Other (2021-2026) & (K Units)
Figure 40. Global Hemoperfusion Sale Market Share by Application (2025)
Figure 41. Global Hemoperfusion Revenue Market Share by Application in 2025
Figure 42. Hemoperfusion Sales by Company in 2025 (K Units)
Figure 43. Global Hemoperfusion Sales Market Share by Company in 2025
Figure 44. Hemoperfusion Revenue by Company in 2025 ($ millions)
Figure 45. Global Hemoperfusion Revenue Market Share by Company in 2025
Figure 46. Global Hemoperfusion Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Hemoperfusion Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Hemoperfusion Sales 2021-2026 (K Units)
Figure 49. Americas Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 50. APAC Hemoperfusion Sales 2021-2026 (K Units)
Figure 51. APAC Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 52. Europe Hemoperfusion Sales 2021-2026 (K Units)
Figure 53. Europe Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Hemoperfusion Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Hemoperfusion Revenue 2021-2026 ($ millions)
Figure 56. Americas Hemoperfusion Sales Market Share by Country in 2025
Figure 57. Americas Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 58. Americas Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 59. Americas Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 60. United States Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Hemoperfusion Sales Market Share by Region in 2025
Figure 65. APAC Hemoperfusion Revenue Market Share by Region (2021-2026)
Figure 66. APAC Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 67. APAC Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 68. China Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 72. India Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Hemoperfusion Sales Market Share by Country in 2025
Figure 76. Europe Hemoperfusion Revenue Market Share by Country (2021-2026)
Figure 77. Europe Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 78. Europe Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 79. Germany Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 80. France Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Hemoperfusion Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Hemoperfusion Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Hemoperfusion Sales Market Share by Application (2021-2026)
Figure 87. Egypt Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Hemoperfusion Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Hemoperfusion in 2026
Figure 93. Manufacturing Process Analysis of Hemoperfusion
Figure 94. Industry Chain Structure of Hemoperfusion
Figure 95. Channels of Distribution
Figure 96. Global Hemoperfusion Sales Market Forecast by Region (2027-2032)
Figure 97. Global Hemoperfusion Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Hemoperfusion Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Hemoperfusion Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Hemoperfusion Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Hemoperfusion Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Medical Tapes Market Growth 2025-2031
US$ 3,660.00
December 2024
166 pages
Global Dental Scalers Market Growth 2023-2029
US$ 3,660.00
March 2023
108 pages
Global Pressure Mode Neonatal Ventilators Market Growth 2024-2030
US$ 3,660.00
March 2024
130 pages
